We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Btg Plc | LSE:BTG | London | Ordinary Share | GB0001001592 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 840.00 | 839.00 | 840.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/10/2018 16:19 | There is a world of pain out there for sufferers with varicose vein and ulcerated legs.With an ageing population and type2 diabetes becoming of epidemic proportions, a steady but focussed business development ofVarithena could yet bring some decent cash flow.At least the board are maintain their support. | fhmktg | |
04/10/2018 11:15 | spyder Have you looked outside of your little rainbow world lately? Do you really think it is "Happy Days"? Get real. | minerve | |
04/10/2018 11:05 | Thanks Minerve, I have been called many things in my time, but never a “simpletonR Also not been trolled before, another first for me. | spyder | |
04/10/2018 10:49 | "Happy days." I hate that saying, it is so moronic. "Happy Days", "Happy Days", FFS, simpletons - don't you just love them. 🙄 | minerve | |
04/10/2018 10:33 | My 1st thought is they have effectively killed it off as a separate line and will now get buried into 'vascular'. Was going to be the company maker many moons ago. | waterloo01 | |
04/10/2018 09:16 | Yup --this seems to be from the school of "it's how you tell them". Yet,having said that, it is also a bit of a relief. Days of the CEO dreaming/suggesting BTG becoming another Shire have slipped away I suspect. Still lets see what the next chapter has to offer | gregmorg | |
04/10/2018 09:01 | "Varithena(R) is expected to become profitable during the 2019/20 financial year and to have peak sales potential in the high tens of millions of dollars. Its sales will be included within the Vascular product sales line going forwards.."But originally,the peak sales potential was identified as being in the hundred of millions of dollars.BTG continues to believe that the results it produces are quite good enough.Its smoke and mirrors.I'd like to believe that everything's rosey but I'll need more convincing. | steeplejack | |
04/10/2018 08:11 | BTG back on track. Chart looks very positive. Varithena is secure. Happy days. | spyder | |
04/10/2018 08:10 | Fantastic update this morning team - just what the doctor ordered :-) | spyder | |
04/10/2018 07:56 | What does it mean 15-17% growth for Varithena ? Varithena was generating 5 mil £ or $ ? 17% means 850k ? Is it correct ? Profitable in 2019-2020 with 6.5 -7.5 mil revenues Profit 500k So how many years to reach high tenths of millions and promised hi hundreds of millions I recall Am I correct ? So Varithena will be able to pay their salaries ? What about shareholders ? 15-17 % growth in Onco Vascular ? What about other products ? Growth or no growth ? Range of target prices from Numis BUY with 840p to UNDERPERFORM 510p from RBC | a1ord53 | |
04/10/2018 07:48 | Please don’t .... :-) | spyder | |
04/10/2018 07:07 | A lot has not been said. However, we know that Varithena is a dog and PneumRx is worth nothing. Uninspiring. | cockneytrader | |
03/10/2018 17:19 | Lol surprised the downticker not bored yet. | bargainbob | |
02/10/2018 20:24 | What a first class plonker the downticker is. | bargainbob | |
02/10/2018 12:45 | Shareprice looking good . Now will the idiot downtick that ? | cannyshoveyergrannyoffthebus | |
01/10/2018 17:58 | Then maybe not canny. | bargainbob | |
01/10/2018 12:24 | the downticker's Mom must be so proud Bob | cannyshoveyergrannyoffthebus | |
30/9/2018 08:13 | Downticker must be off the last few days. | bargainbob | |
28/9/2018 18:05 | I see what you mean canny , needs to get a life. | bargainbob | |
28/9/2018 03:05 | I see the phantom downticker had a day off. | bargainbob | |
27/9/2018 08:33 | The replacement policy for Crofab is defensive, of course, but taken together with the other moves place pressure on Anavip to match them, increasing their costs of entry into the market.Confidence in efficacy is proven for Crofab and they are extending their range of indications.All good moves for a market leader to defend their position.Real price moves might come later, but not until Anavip actually starts to impact on stock ordering.The actual launch and pricing policy for Anavip are still not announced as far as I know.The next 12-18 months will be 'interesting'Much more important this year is the ongoing policy for Varithena......... | fhmktg | |
27/9/2018 07:30 | I see the phantom downticker was busy last night. | bargainbob |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions